Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343499
Status:
TERMINATED
Last Update Posted:
2008-08-21
First Post:
2006-06-21
Brief Title:
The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial the DRAFT Trial
Sponsor:
Intermountain Health Care Inc
Organization:
Intermountain Health Care Inc
Organization Data
Organization:
Intermountain Health Care Inc
Class:
OTHER
Study ID:
128-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Intermountain Health Care Inc
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |